Search

Your search keyword '"Roland, Lauren T."' showing total 28 results
Start Over Author "Roland, Lauren T." Publisher wiley
28 results on '"Roland, Lauren T."'

5. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

Author

Wise, Sarah K., primary, Damask, Cecelia, additional, Roland, Lauren T., additional, Ebert, Charles, additional, Levy, Joshua M., additional, Lin, Sandra, additional, Luong, Amber, additional, Rodriguez, Kenneth, additional, Sedaghat, Ahmad R., additional, Toskala, Elina, additional, Villwock, Jennifer, additional, Abdullah, Baharudin, additional, Akdis, Cezmi, additional, Alt, Jeremiah A., additional, Ansotegui, Ignacio J., additional, Azar, Antoine, additional, Baroody, Fuad, additional, Benninger, Michael S., additional, Bernstein, Jonathan, additional, Brook, Christopher, additional, Campbell, Raewyn, additional, Casale, Thomas, additional, Chaaban, Mohamad, additional, Chew, Fook Tim, additional, Chambliss, Jeffrey, additional, Cianferoni, Antonella, additional, Custovic, Adnan, additional, Davis, Elizabeth Mahoney, additional, DelGaudio, John M., additional, Ellis, Anne K., additional, Flanagan, Carrie, additional, Fokkens, Wytske J., additional, Franzese, Christine, additional, Greenhawt, Matthew, additional, Gill, Amarbir, additional, Halderman, Ashleigh, additional, Hohlfeld, Jens M., additional, Incorvaia, Cristoforo, additional, Joe, Stephanie A., additional, Joshi, Shyam, additional, Kuruvilla, Merin Elizabeth, additional, Kim, Jean, additional, Klein, Adam M., additional, Krouse, Helene J., additional, Kuan, Edward C., additional, Lang, David, additional, Larenas‐Linnemann, Desiree, additional, Laury, Adrienne M., additional, Lechner, Matt, additional, Lee, Stella E., additional, Lee, Victoria S., additional, Loftus, Patricia, additional, Marcus, Sonya, additional, Marzouk, Haidy, additional, Mattos, Jose, additional, McCoul, Edward, additional, Melen, Erik, additional, Mims, James W., additional, Mullol, Joaquim, additional, Nayak, Jayakar V., additional, Oppenheimer, John, additional, Orlandi, Richard R., additional, Phillips, Katie, additional, Platt, Michael, additional, Ramanathan, Murugappan, additional, Raymond, Mallory, additional, Rhee, Chae‐Seo, additional, Reitsma, Sietze, additional, Ryan, Matthew, additional, Sastre, Joaquin, additional, Schlosser, Rodney J., additional, Schuman, Theodore A., additional, Shaker, Marcus S., additional, Sheikh, Aziz, additional, Smith, Kristine A., additional, Soyka, Michael B., additional, Takashima, Masayoshi, additional, Tang, Monica, additional, Tantilipikorn, Pongsakorn, additional, Taw, Malcolm B., additional, Tversky, Jody, additional, Tyler, Matthew A., additional, Veling, Maria C., additional, Wallace, Dana, additional, Wang, De Yun, additional, White, Andrew, additional, Zhang, Luo, additional, Ahmed, Omar G., additional, Arianpour, Khashayar, additional, Barrow, Emily, additional, Cavaliere, Carlo, additional, Cantu, Juan Carlos Ceballos, additional, Chaskes, Mark B., additional, Chua, Andy Jian Kai, additional, Daggumati, Srihari, additional, Daines, Luke, additional, Daraei, Paul, additional, Edwards, Thomas, additional, Gigliotti, Deanna, additional, Gore, Mitchell, additional, Goshtasbi, Khodayar, additional, Han, Doo Hee, additional, Hossenbaccus, Lubnaa, additional, Jolicoeur, Megan, additional, Kanjanawasee, Dichapong, additional, Kilic, Suat, additional, Linton, Sophia, additional, Liu, David, additional, Low, Christoper, additional, Mahomva, Chengetai, additional, Malenke, Jordan A., additional, Miglani, Amar, additional, Nagy, Peter, additional, Park, Jin‐A, additional, Paz‐Lansberg, Marianella, additional, Pfeffer, Paul, additional, Ryan, Marisa, additional, Saraswathula, Anirudh, additional, Sheehan, Cameron, additional, Struss, Nadja, additional, Tie, Kevin, additional, Torabi, Sina, additional, Tsai, Esmond F., additional, Velasquez, Nathalia, additional, Vuncannon, Jackson, additional, Watley, Duncan, additional, and Xu, Xinni, additional

Published
2023
Full Text
View/download PDF

6. Diagnosis, prognosticators, and management of acute invasive fungal rhinosinusitis: multidisciplinary consensus statement and Evidence‐Based review with recommendations

Author

Roland, Lauren T., primary, Humphreys, Ian M., additional, Le, Christopher H., additional, Babik, Jennifer M., additional, Bailey, Christopher E., additional, Ediriwickrema, Lilangi S., additional, Fung, Monica, additional, Lieberman, Joshua A., additional, Magliocca, Kelly R., additional, Nam, Hannah H., additional, Teo, Neville W., additional, Thomas, Penelope C., additional, Winegar, Blair A., additional, Birkenbeuel, Jack L., additional, David, Abel P., additional, Goshtasbi, Khodayar, additional, Johnson, Patricia G., additional, Martin, Elaine C., additional, Nguyen, Theodore V, additional, Patel, Neil N., additional, Qureshi, Hannan A., additional, Tay, Kaijun, additional, Vasudev, Milind, additional, Abuzeid, Waleed M., additional, Hwang, Peter H., additional, Jafari, Aria, additional, Russell, Matthew S., additional, Turner, Justin H., additional, Wise, Sarah K., additional, and Kuan, Edward C., additional

Published
2023
Full Text
View/download PDF

9. What is allergic fungal sinusitis: A call to action

Author

Kim, Jean, primary, Makary, Chadi A., additional, Roland, Lauren T., additional, Kuruvilla, Merin, additional, Lam, Kent, additional, Smith, Kristine A., additional, Magliocca, Kelly R., additional, Wise, Sarah K., additional, Toskala, Elina, additional, Fermin, Janmaris Marin, additional, Pashley, Catherine H., additional, Levy, Joshua M., additional, and Luong, Amber U., additional

Published
2021
Full Text
View/download PDF

16. Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health–sponsored workshop

Author

Roland, Lauren T., primary, Smith, Timothy L., additional, Schlosser, Rodney J., additional, Soler, Zachary M., additional, Peters, Anju T., additional, Laidlaw, Tanya M., additional, Bleier, Benjamin S., additional, Ramakrishnan, Vijay, additional, Toskala, Elina, additional, Kennedy, David W., additional, and Luong, Amber U., additional

Published
2020
Full Text
View/download PDF

28. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study.

Author

Peterson AM, Miller BJ, Kallogjeri D, Piccirillo JF, Kukuljan S, Roland LT, Schneider JS, Crock LW, and Farrell NF

Subjects
Adult, Humans, Middle Aged, Smell, Pilot Projects, Quality of Life, Stellate Ganglion, COVID-19 Testing, COVID-19 complications, Olfaction Disorders etiology, Olfaction Disorders therapy, Olfaction Disorders diagnosis
Abstract

Objective: The objective of this study was to explore the safety and feasibility of stellate ganglion blocks (SGBs) to treat persistent COVID-19-induced olfactory dysfunction (OD). Secondarily, the goal was to determine effect sizes to plan a future randomized clinical trial., Study Design: Prospective case series., Setting: Quaternary Care Academic Medical Center., Methods: In this single-arm pilot trial, adult participants with a COVID-19 diagnosis ≥ 12 months prior to enrollment with OD underwent bilateral SGBs. Subjects were followed for 1 month after completion of SGB. The primary outcome measure was the change in the Clinical Global Impression-Improvement Scale for smell loss. Secondary outcome measures included changes in the University of Pennsylvania Smell Identification Test (UPSIT) and Olfactory Dysfunction Outcomes Rating (ODOR)., Results: Twenty participants were enrolled with a mean (SD) age of 46 (11) years and a mean (SD) duration of OD of 21 (5) months. At 1 month, 10 (50%) participants experienced at least slight subjective improvement in their OD, 11 (55%) attained a clinically meaningful improvement in smell identification using the UPSIT, and 7 (35%) achieved a clinically meaningful improvement in olfactory-specific quality of life (QoL) measured by the ODOR. The median difference between UPSIT scores at baseline and 1 month was 6 (95% confidence interval: 3-11), exceeding the minimal clinically important difference of 4. There were no serious adverse events., Conclusion: Sequential SGBs for COVID-19-associated OD were safe and associated with modest improvements in subjective olfaction, odor identification, and olfactory-specific QoL. A placebo-controlled trial is warranted to determine the efficacy of SGBs for COVID-19-associated OD., (© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results